SEC Form 4 · accession 0001567619-18-008315
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jean Jacques Bienaime
Officer — Chief Executive Officer · Director
Period of report
Dec 14, 2018
Accepted (ET)
Dec 18, 2018 · 7:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 19, 2018 | G | 160 | $0.00 | D | 182,041 | I | Shares held by Jean-Jacques Bienaime Family Trust |
| Common StockF2 | Nov 20, 2018 | G | 540 | $0.00 | D | 181,501 | I | Shares held by Jean-Jacques Bienaime Family Trust |
| Common StockF3 | Dec 14, 2018 | M | 2,000 | $17.86 | A | 290,290 | D | |
| Common StockF3 | Dec 14, 2018 | S | 2,000 | $92.64 | D | 288,290 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to buy Common Stock)F3,F4 | $17.86 | Dec 14, 2018 | M | 2,000 | D | Jun 17, 2009 | Dec 16, 2018 | Common Stock | 2,000 | 0 | D |
Explanation of responses
- F1On November 19, 2018, the reporting entity gifted 160 shares to an educational institution.
- F2On November 20, 2018, the reporting entity gifted 540 shares to a non-profit organization.
- F3Trade made pursuant to a 10b5-1 plan executed on May 21, 2018.
- F4Reflects the number of options outstanding after the transactions from this specific stock option grant.